ArticleCancer science2016

Enhanced gefitinib-induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia-mutated kinase inhibition in non-small-cell lung cancer cells.

Keizo Misumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.